In this context, we investigated the predictive ability of high sensitivity troponin I (hsTnI) for the incidence of AF across different European populations from the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) consortium in comparison to CVRF and the established biomarkers NT‐proBNP and CRP. This evidence concerns the gene CRP and atrial fibrillation.